Results 151 to 160 of about 4,373 (200)
A Unique Case of Non-paraneoplastic Lambert-Eaton Myasthenic Syndrome Treated With Subcutaneous Immunoglobulin: A Case Report and Review of Literature. [PDF]
CureusPark SK, Taylor MG.
europepmc +1 more source
Independence in activities of daily living was achieved using aerobic exercise without overwork weakness during rehabilitation: a case report of Lambert-Eaton myasthenic syndrome. [PDF]
J Phys Ther SciHarayama E, Goto K, Yamauchi K.
europepmc +1 more source
Lambert-Eaton myasthenic syndrome
, 2014 Henry Knipe, Rohit Sharma, Hamish Smith
openaire +1 more source
Long-term Follow-up, Quality of Life, and Survival of Patients With Lambert-Eaton Myasthenic Syndrome. [PDF]
Neurology, 2021 europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lambert–Eaton myasthenic syndrome
British Journal of Hospital Medicine, 2009A 64-year-old man presented with proximal lower limb muscle weakness that had ascended over 3 months to involve the upper limb, bulbar and periocular muscles. In addition, he had muscle aches, dry eyes and mouth, with 10 kg of weight loss. He was an ex-smoker of 50 pack-years.
Yi Zhen, Chiang +2 more
+10 more sources
Lambert-Eaton Myasthenic Syndrome [PDF]
Neurologic Clinics, 2018 Lambert-Eaton myasthenic syndrome is a paraneoplastic or primary autoimmune neuromuscular junction disorder characterized by proximal weakness, autonomic dysfunction and ariflexia. The characteristic symptoms are thought to be caused by antibodies generated against the P/Q-type voltage-gated calcium channels present on presynaptic nerve terminals and ...
Shin J Oh +2 more
exaly +3 more sources
Lambert-Eaton Myasthenic Syndrome
Seminars in Neurology, 2004Lambert-Eaton myasthenic syndrome (LEMS) is an idiopathic or paraneoplastic syndrome producing antibodies against presynaptic voltage-gated P/Q calcium channels. This decreases calcium entry into the presynaptic terminal, which prevents binding of vesicles to the presynaptic membrane and acetylcholine release.
Laurie Gutmann
exaly +3 more sources
3,4-diaminopyridine for the treatment of Lambert–Eaton myasthenic syndrome
Expert Review of Clinical Immunology, 2010 The Lambert Eaton myasthenic syndrome (LEMS) is an autoimmune disease in which antibodies against voltage-gated calcium channels inhibit cholinergic neurotransmission LEMS is clinically characterized by muscle weakness and autonomic dysfunction 3 4 ...
Paul W Wirtz +2 more
exaly +2 more sources